Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...
JCPenney and Ashley Graham defy the Ozempic trend with a bold, size-inclusive campaign that celebrates curves and drives ...
Fans are speculating about Demi Lovato’s look after her latest appearances. See Demi’s 2025 transformation photos ...
A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...
Investor's Business Daily on MSN
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.
A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...
LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive ...
Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U. obesity ...
Roblox posted a wider third-quarter loss but boosted its revenue forecast for the year as a pair of videogaming crazes generated robust top-line growth. Fox logged higher revenue in its fiscal first ...
Celebrities open up about using Ozempic and weight loss injections, sharing their stories, results, and side effects ...
The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results